Top 20 Shareholders 31st October 2018
Top_Holder_-_Detail_-_Single_Date October
Drug Reformulation Play With Significant Potential
2018 11 05 PharmAust report from NDF Research This report has been commissioned and paid for by PharmAust (Company) and has been prepared by NDF Research, an Authorised Representative of BR Securities Australia Pty Ltd. The report solely reflects the views of Pitt Street Research. Any opinions, forecasts, recommendations or forward-looking statements in the report…